drugset / Trial / NCT07212452

Tranexamic Acid : Nebulization vs IV Route for Hemoptysis

NCT07212452 ↗

Phase 2/3 Completed 172 enrolled University of Health Sciences Lahore
RandomizedParallel-groupOpen-labelTreatment

Summary

This study compares the effect of tranexamic acid on hemoptysis when given through the conventional IV route and Through nebulization.

Timeline

Start
2025-08-01
Primary completion
2025-10-31
Completion
2025-10-31

Outcome

Met primary endpoint

paper significantly higher in the nebulization arm (n = 40) compared with the IV arm (n = 28): χ2 (1, n = 110) = 5.55; P = .0019. PMID 36410494 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 500 mg Intravenous

Indications

No indication recorded.